Takashi Taga

4.2k total citations
114 papers, 1.5k citations indexed

About

Takashi Taga is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Takashi Taga has authored 114 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 38 papers in Public Health, Environmental and Occupational Health and 31 papers in Molecular Biology. Recurrent topics in Takashi Taga's work include Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (37 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Takashi Taga is often cited by papers focused on Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (37 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Takashi Taga collaborates with scholars based in Japan, United States and Singapore. Takashi Taga's co-authors include Souichi Adachi, Walter E. Laug, Daisuke Tomizawa, Hiroyuki Shimada, Berislav V. Zloković, Tobey J. MacDonald, David A. Cheresh, Peyman Tabrizi, Hiroyuki Takahashi and Akio Tawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Takashi Taga

108 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takashi Taga Japan	20	675	637	359	279	220	114	1.5k
Gerlinde Mitterbauer Austria	27	1.1k 1.6×	645 1.0×	399 1.1×	404 1.4×	223 1.0×	57	1.8k
C.A. Griffin United States	21	619 0.9×	795 1.2×	173 0.5×	308 1.1×	419 1.9×	41	2.1k
Ryan D. Cassaday United States	21	354 0.5×	456 0.7×	378 1.1×	214 0.8×	1.0k 4.6×	138	2.0k
R Schirò Italy	20	558 0.8×	351 0.6×	121 0.3×	318 1.1×	324 1.5×	35	1.2k
Todd W. Kelley United States	26	426 0.6×	707 1.1×	200 0.6×	443 1.6×	325 1.5×	68	2.0k
Seiji Kojima Japan	20	414 0.6×	308 0.5×	145 0.4×	175 0.6×	213 1.0×	40	1.1k
DG Gilliland United States	15	1.2k 1.7×	744 1.2×	484 1.3×	473 1.7×	159 0.7×	19	2.0k
Friedrich Wimazal Austria	24	1.1k 1.7×	344 0.5×	136 0.4×	626 2.2×	189 0.9×	52	2.0k
M. Y. Gordon United Kingdom	22	714 1.1×	453 0.7×	83 0.2×	448 1.6×	290 1.3×	65	1.4k
K Sugita Japan	21	270 0.4×	329 0.5×	157 0.4×	95 0.3×	230 1.0×	41	1.4k

Countries citing papers authored by Takashi Taga

Since Specialization

Citations

This map shows the geographic impact of Takashi Taga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Taga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Taga more than expected).

Fields of papers citing papers by Takashi Taga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Taga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Taga. The network helps show where Takashi Taga may publish in the future.

Co-authorship network of co-authors of Takashi Taga

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Taga. A scholar is included among the top collaborators of Takashi Taga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Taga. Takashi Taga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Shota, Kentaro Nakashima, Genki Yamato, et al.. (2024). Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan. Pediatric Blood & Cancer. 71(10). e31244–e31244.

Aoki, Takahiro, Norio Shiba, Shin‐ichi Tsujimoto, et al.. (2023). High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor. Pediatric Blood & Cancer. 71(2). e30803–e30803. 5 indexed citations

Sakaguchi, Hirotoshi, Itaru Kato, Kimiyoshi Sakaguchi, et al.. (2023). Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I–II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21). BMJ Open. 13(4). e070051–e070051. 2 indexed citations

Hama, Asahito, Takashi Taga, Daisuke Tomizawa, et al.. (2023). Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome. British Journal of Haematology. 201(4). 747–756. 2 indexed citations

Sakamoto, Kenichi, et al.. (2022). Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7. International Journal of Hematology. 116(4). 635–638. 4 indexed citations

Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations

Yamamoto, Shohei, Daisuke Tomizawa, Kazuko Kudo, et al.. (2020). Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan. Pediatric Blood & Cancer. 67(5). e28181–e28181. 5 indexed citations

Hyakuna, Nobuyuki, Yoshiko Hashii, Hiroyuki Ishida, et al.. (2019). Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial. Pediatric Blood & Cancer. 66(10). e27875–e27875. 8 indexed citations

Sakamoto, Kenichi, Norio Shiba, Takao Deguchi, et al.. (2019). Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study. British Journal of Haematology. 187(3). 372–376. 9 indexed citations

10.

Miyamura, Takako, Hiroshi Moritake, Hideki Nakayama, et al.. (2019). Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study. British Journal of Haematology. 185(2). 284–288. 15 indexed citations

11.

Nakashima, Kentaro, Daisuke Hasegawa, Daisuke Tomizawa, et al.. (2019). Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities. Pediatric Blood & Cancer. 66(11). e27942–e27942. 1 indexed citations

12.

Matsuo, H., Yuka Iijima‐Yamashita, Miho Yamada, et al.. (2017). Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia. Pediatrics International. 60(1). 41–46. 12 indexed citations

13.

Nakayama, Hideki, Daisuke Tomizawa, Shiro Tanaka, et al.. (2017). Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. Pediatrics International. 59(10). 1046–1052. 6 indexed citations

14.

Iijima‐Yamashita, Yuka, H. Matsuo, Miho Yamada, et al.. (2017). Multiplex fusion gene testing in pediatric acute myeloid leukemia. Pediatrics International. 60(1). 47–51. 9 indexed citations

15.

Miyamura, Takako, Katsuyoshi Koh, Takashi Taga, et al.. (2015). Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group. International Journal of Hematology. 102(6). 697–701. 6 indexed citations

16.

Suzuki, Mikio, et al.. (2005). A Case of Rhabdomyosarcoma in the Maxillary Sinus. Practica Oto-Rhino-Laryngologica. 98(6). 471–475. 1 indexed citations

17.

Kato, Hirofumi, et al.. (2003). Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: Differentiation‐induction using 5‐azacytidine. Cancer Science. 94(12). 1059–1065. 8 indexed citations

18.

Kato, Hirofumi, et al.. (2002). Estrogen Receptor Expression and Estrogen Receptor‐independent Cytotoxic Effects of Tamoxifen on Malignant Rhabdoid Tumor Cells in vitro. Japanese Journal of Cancer Research. 93(12). 1351–1357. 8 indexed citations

19.

Suzuki, Akira, et al.. (2001). Three-year-old boy with primary rhabdomyosarcoma of the diaphragm presenting with a hemothorax. 7. 305–309. 1 indexed citations

20.

Taga, Takashi, et al.. (2001). The Autocrine Loop of Epidermal Growth Factor Receptor‐Epidermal Growth Factor/Transforming Growth Factor‐α in Malignant Rhabdoid Tumor Cell Lines: Heterogeneity of Autocrine Mechanism in TTC549. Japanese Journal of Cancer Research. 92(3). 269–278. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact